OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Integration of In Silico Strategies for Drug Repositioning towards P38α Mitogen-Activated Protein Kinase (MAPK) at the Allosteric Site
Utid Suriya, Panupong Mahalapbutr, Thanyada Rungrotmongkol
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1461-1461
Open Access | Times Cited: 12
Utid Suriya, Panupong Mahalapbutr, Thanyada Rungrotmongkol
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1461-1461
Open Access | Times Cited: 12
Showing 12 citing articles:
Function and inhibition of P38 MAP kinase signaling: Targeting multiple inflammation diseases
Jiahui Wang, Yongjian Liu, Yushi Guo, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115973-115973
Closed Access | Times Cited: 21
Jiahui Wang, Yongjian Liu, Yushi Guo, et al.
Biochemical Pharmacology (2023) Vol. 220, pp. 115973-115973
Closed Access | Times Cited: 21
Reversal of chemotherapy resistance in gastric cancer with traditional Chinese medicine as sensitizer: potential mechanism of action
Chencong Zhou, Kaihan Wu, M. Gu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Chencong Zhou, Kaihan Wu, M. Gu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Phenolics from Ilex rotunda Possess Antioxidative Effects and Block Activation of MAPK and NF-κB Signaling by Inhibiting IL-2 Production in CD3/CD8 Activated Jurkat T Cells
Duc Dat Le, Vinhquang Truong, Thinhulinh Dang, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 281-281
Open Access
Duc Dat Le, Vinhquang Truong, Thinhulinh Dang, et al.
Antioxidants (2025) Vol. 14, Iss. 3, pp. 281-281
Open Access
Discovery of furopyridine-based compounds as novel inhibitors of Janus kinase 2: In silico and in vitro studies
Utid Suriya, Panupong Mahalapbutr, Athina Geronikaki, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129308-129308
Closed Access | Times Cited: 4
Utid Suriya, Panupong Mahalapbutr, Athina Geronikaki, et al.
International Journal of Biological Macromolecules (2024) Vol. 260, pp. 129308-129308
Closed Access | Times Cited: 4
Lomitapide repurposing for treatment of malignancies: A promising direction
Hua-Tao Wu, Bingxuan Wu, Ze-Xuan Fang, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32998-e32998
Open Access | Times Cited: 1
Hua-Tao Wu, Bingxuan Wu, Ze-Xuan Fang, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32998-e32998
Open Access | Times Cited: 1
Natural Compounds for Bone Remodeling: A Computational and Experimental Approach Targeting Bone Metabolism-Related Proteins
Alexandros-Timotheos Loukas, Michail Papadourakis, Vasilis Panagiotopoulos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5047-5047
Open Access | Times Cited: 1
Alexandros-Timotheos Loukas, Michail Papadourakis, Vasilis Panagiotopoulos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5047-5047
Open Access | Times Cited: 1
Quinoxalinones as A Novel Inhibitor Scaffold for EGFR (L858R/T790M/C797S) Tyrosine Kinase: Molecular Docking, Biological Evaluations, and Computational Insights
Utid Suriya, Panupong Mahalapbutr, Watchara Wimonsong, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8901-8901
Open Access | Times Cited: 7
Utid Suriya, Panupong Mahalapbutr, Watchara Wimonsong, et al.
Molecules (2022) Vol. 27, Iss. 24, pp. 8901-8901
Open Access | Times Cited: 7
A combination of structure-based virtual screening and experimental strategies to identify the potency of caffeic acid ester derivatives as SARS-CoV-2 3CLpro inhibitor from an in-house database
Piyatida Pojtanadithee, Kulpornsorn Isswanich, Koonchira Buaban, et al.
Biophysical Chemistry (2023) Vol. 304, pp. 107125-107125
Open Access | Times Cited: 3
Piyatida Pojtanadithee, Kulpornsorn Isswanich, Koonchira Buaban, et al.
Biophysical Chemistry (2023) Vol. 304, pp. 107125-107125
Open Access | Times Cited: 3
Computational Advancements and In Vitro Evaluation in Pre-clinical Anticancer Drug Discovery and Development
Utid Suriya, Boonyarut Ladda, Bodee Nutho, et al.
Interdisciplinary cancer research (2024)
Closed Access
Utid Suriya, Boonyarut Ladda, Bodee Nutho, et al.
Interdisciplinary cancer research (2024)
Closed Access
Biological Evaluation of 2-(3,4-dihydroxyphenyl)-4-((4-methoxyphenyl)imino)-4H-chromene-3,5,7-triol: Design, Synthesis, and Molecular Docking Studies
Udaya Rajesh R, D. Sangeetha
Biocatalysis and Agricultural Biotechnology (2024), pp. 103471-103471
Closed Access
Udaya Rajesh R, D. Sangeetha
Biocatalysis and Agricultural Biotechnology (2024), pp. 103471-103471
Closed Access
Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validation
Chawalit Ngernsombat, Utid Suriya, Pongphol Prattapong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Chawalit Ngernsombat, Utid Suriya, Pongphol Prattapong, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
A Combination of Structure-based Virtual Screening and Experimental Strategies to Identify the Potency of Caffeic Acid Ester Derivatives as SARS-CoV-2 3CLpro Inhibitor from an In-house Database
Piyatida Pojtanadithee, Kulpornsorn Isswanich, Koonchira Buaban, et al.
Research Square (Research Square) (2023)
Open Access
Piyatida Pojtanadithee, Kulpornsorn Isswanich, Koonchira Buaban, et al.
Research Square (Research Square) (2023)
Open Access
